Machine learning has long been used at UMC. In fact, our vigiGroup method stems from neural networks pioneered by one of this year’s Nobel laureates in Physics.

In focus / 05 December 2024

Compared to the general population, older adults are more at risk of experiencing adverse drug reactions. Why is this the case, and what does this mean for pharmacovigilance?

In focus / 29 October 2024

Pharmacovigilance monitors the safety of the medicines we use, but what about those that get into our environment?

In focus / 15 October 2024

EcoPV aims to monitor and manage the environmental impact of pharmaceuticals. How may we best support this effort?

In focus / 01 September 2024